These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38602625)

  • 1. The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects.
    Cao B; Ma T; Zhang Y; Huang L; Lin H; Jiang H; Zhao Y; Geng Y; Yang Y; Cao S; Li J
    Invest New Drugs; 2024 Jun; 42(3):289-298. PubMed ID: 38602625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 1 study to evaluate the effects of rifampin or itraconazole on the pharmacokinetics of limertinib (ASK120067), a novel mutant-selective inhibitor of the epidermal growth factor receptor in healthy Chinese subjects.
    Cao B; Huang L; Liu M; Lin H; Ma T; Zhao Y; Geng Y; Yang Y; Guo H; Li J
    Expert Opin Drug Metab Toxicol; 2023 Sep; 19(9):653-664. PubMed ID: 37811634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects.
    Hu L; Dou T; Sun Q; Tang L; Cai M; Qian W; Wang H
    Invest New Drugs; 2023 Apr; 41(2):276-283. PubMed ID: 36800130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Food Intake on Pharmacokinetics of Oral Almonertinib: A Randomized Crossover Trial in Healthy Chinese Participants.
    Ji W; Jiang Y; Wei Y; He K; Mu H; Wen Q; Zhang X
    Clin Pharmacol Drug Dev; 2022 Sep; 11(9):1046-1053. PubMed ID: 35437951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects.
    Kuang Y; Song HL; Yang GP; Pei Q; Yang XY; Ye L; Yang S; Wu ST; Guo C; He QN; Huang J
    Cancer Chemother Pharmacol; 2020 Sep; 86(3):339-346. PubMed ID: 32757049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers.
    Du P; Long Y; Wang M; Huang Y; Wang Y; Chen X; Lin Y; Wu J; Shen J; Jia Y
    Cancer Chemother Pharmacol; 2024 Aug; 94(2):251-257. PubMed ID: 38703321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects.
    Qian H; Wu X; Chen Q; Li T; Wang W; Jia J; Yu C; Li K; Sai Y; Su W; Liu Y
    Clin Ther; 2020 Sep; 42(9):1778-1786. PubMed ID: 32800383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions.
    Liu Y; Cheng J; Liang L; Qian W; Ou M; Zhang M; Wang Y; Wang Y; Peng K; Jia J
    PLoS One; 2023; 18(4):e0284576. PubMed ID: 37083730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males.
    Li J; Tan Y; Li K; Hui AM; Wu Z; Han P; Wei Z; Qiu J; Diao L; Wang X
    Adv Ther; 2023 Mar; 40(3):1074-1086. PubMed ID: 36627544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
    Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects.
    Qian H; Fan S; Li K; Sai Y; Su W; Chen Q; Liu Y; Li T; Wang W; Jia J; Yu C; Liu Y
    Clin Ther; 2019 Aug; 41(8):1537-1544. PubMed ID: 31272709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
    Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
    Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.
    Hu L; Sun Q; Tang L; Cai M; Qian W; Dou T; Wang H; Wu Y; Liu Y
    Clin Drug Investig; 2024 Jan; 44(1):79-85. PubMed ID: 38112942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of vandetanib: three phase I studies in healthy subjects.
    Martin P; Oliver S; Kennedy SJ; Partridge E; Hutchison M; Clarke D; Giles P
    Clin Ther; 2012 Jan; 34(1):221-37. PubMed ID: 22206795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
    Wu J; Xu H; Li H; Ma L; Chen J; Yuan F; Sheng L; Liu C; Chen W; Li X
    Drug Des Devel Ther; 2023; 17():761-769. PubMed ID: 36925997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.
    Liu X; Xue L; Zhang H; Xu Q; Zhang S; Ma S; Ding X; Liu L; Dong J; Qian L; Xia W; Jiang K; Huang C; Miao L
    Clin Drug Investig; 2020 Jun; 40(6):555-566. PubMed ID: 32277364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
    Wang J; Zhang H; Wang R; Cai Y
    Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
    Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
    BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence study of two formulations of flupirtine maleate capsules in healthy male Chinese volunteers under fasting and fed conditions.
    Liu Y; Huo H; Zhao Z; Hu W; Sun Y; Tang Y
    Drug Des Devel Ther; 2017; 11():3441-3448. PubMed ID: 29238169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
    Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
    Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.